IP Library Granted Patent US 6,992,171
Granted Patent B2
US 6,992,171 · App. 10/297,895 · Granted Jan 31, 2006

Polypeptide and its DNA

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,992,171
App. No.
10/297,895
Granted
Jan 31, 2006
Kind
B2
Abstract

It is intended to construct a screening method, etc. for searching for compounds which are capable of binding to apolipoprotein A-I and thus promote or inhibit the binding of a cubulin fragment to apolipoprotein A-I, and provide preventives or remedies containing compounds obtained by the above screening method, etc. These compounds, etc. are usable in preventives and remedies for various diseases in which cubulin participates and the like.

Claims (2)

1. An isolated polypeptide, amide or ester thereof, or salt thereof consisting of the amino acid sequence of SEQ ID NO: 19.

2. A pharmaceutical composition comprising the isolated polypeptide, amide or ester thereof, or salt thereof of claim 1 and a pharmaceutically acceptable carrier, excipient or diluent.

Assignments (2)
CHANGE OF NAME Recorded Jun 17, 2005
From: TAKEDA CHEMICAL INDUSTRIES, LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 016914/0285 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2002
From: KITA, SHUNBUN; TANIYAMA, YOSHIO
To: TAKEDA CHEMICAL INDUSTRIES, LTD
Reel/Frame 013817/0095 →